To rule out the influence of endogenous PI3K/AKT/mTOR molecules in MSCs, we assessed S6K and p‐AKT levels using FACS within the PBMCs of RA patients (Figure 2B). The gene discussed is RPS6KB1; the disease is rheumatoid arthritis.